Cell therapy enhances function of remote non-infarcted myocardium.
about
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts.Controlling the structural and functional anisotropy of engineered cardiac tissues.Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in ratsCardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calciumThe embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscleTranscription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.Anisotropic engineered heart tissue made from laser-cut decellularized myocardium.Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applicationsUpregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation.Cell-based delivery of dATP via gap junctions enhances cardiac contractility.Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue.Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.Global contractility increment in nonischemic dilated cardiomyopathy after free wall-only intramyocardial injection of autologous bone marrow mononuclear cells: an insight over stem cells clinical mechanism of action.
P2860
Q24652369-7984B1A1-5C3B-4A9A-828A-3A135585C760Q30582828-03D6BADF-F195-4EBE-9043-FDBE824B9B08Q33692557-054F4BF5-44B8-45CA-8AA5-CAFEC97D2AEBQ34355730-A550091C-D05F-4B7E-A4B4-F74F722FF42BQ34634141-79EFA21E-1F62-4C0F-96AD-C71F22343009Q35556284-25C6E07F-685C-4DE0-8C88-0DEBADA54337Q35784455-3E46C45C-0E96-4A09-AD64-E79344CB71C9Q35993918-7E4CD3E3-8E6A-4281-954D-FC8978895996Q36116195-5E773A77-3DE4-4F30-B900-06F737DF1D8CQ36661266-18FF7CCC-D3A4-404F-A8D3-CA6B02DC7163Q38950646-1F51C0A1-4DA9-408E-94C7-67099058649FQ41375244-4D71A82C-8113-4F7F-954E-B6321423E2E7Q43276365-2F43F433-5E29-4518-836E-2753AEF65B81Q47194146-A6929D95-1A9A-4D13-9500-59ED7990582AQ53318735-4C2BD408-9F31-4FBA-8991-F69EB2DE8440
P2860
Cell therapy enhances function of remote non-infarcted myocardium.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell therapy enhances function of remote non-infarcted myocardium.
@en
Cell therapy enhances function of remote non-infarcted myocardium.
@nl
type
label
Cell therapy enhances function of remote non-infarcted myocardium.
@en
Cell therapy enhances function of remote non-infarcted myocardium.
@nl
prefLabel
Cell therapy enhances function of remote non-infarcted myocardium.
@en
Cell therapy enhances function of remote non-infarcted myocardium.
@nl
P2093
P2860
P1476
Cell therapy enhances function of remote non-infarcted myocardium.
@en
P2093
Alicia Moreno-Gonzalez
Charles E Murry
F Steven Korte
Hans Reinecke
Michael Regnier
P2860
P304
P356
10.1016/J.YJMCC.2009.07.030
P577
2009-08-14T00:00:00Z